2.要約四半期連結財務諸表及び主な注記

(1)要約四半期連結財政状態計算書

 

 

 

(単位:千円)

 

前連結会計年度

(2024年12月31日)

 

当第1四半期連結会計期間

(2025年3月31日)

資産

 

 

 

非流動資産

 

 

 

有形固定資産

5,696,491

 

5,323,506

使用権資産

1,559,345

 

1,644,663

のれん

15,994,981

 

15,131,955

無形資産

11,026,585

 

11,353,912

持分法で会計処理されている投資

386,978

 

356,756

繰延税金資産

2,234,803

 

2,236,628

その他の金融資産

5,764,350

 

5,386,252

その他の非流動資産

56,730

 

70,977

非流動資産合計

42,720,266

 

41,504,653

 

 

 

 

流動資産

 

 

 

棚卸資産

2,529,642

 

2,938,705

営業債権及びその他の債権

6,236,284

 

5,552,571

その他の金融資産

9,291,037

 

7,227,867

その他の流動資産

1,050,642

 

845,930

現金及び現金同等物

10,115,037

 

9,931,626

流動資産合計

29,222,643

 

26,496,700

資産合計

71,942,909

 

68,001,354

 

 

 

 

負債及び資本

 

 

 

非流動負債

 

 

 

借入金

1,200,000

 

1,100,000

リース負債

735,590

 

819,860

繰延税金負債

2,171,430

 

2,077,622

その他の金融負債

15,454,160

 

14,955,452

その他の非流動負債

203,422

 

398,135

非流動負債合計

19,764,605

 

19,351,070

 

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

2,263,911

 

1,673,971

借入金

4,575,000

 

3,950,000

1年内返済予定の長期借入金

400,000

 

400,000

リース負債

295,289

 

352,466

未払法人所得税

2,611,203

 

2,708,863

その他の金融負債

888

 

919

その他の流動負債

2,318,111

 

2,905,010

流動負債合計

12,464,403

 

11,991,230

負債合計

32,229,009

 

31,342,301

 

 

 

 

資本

 

 

 

資本金

13,276,700

 

13,322,100

資本剰余金

6,626,254

 

6,638,077

自己株式

15,372

 

15,490

利益剰余金

9,888,797

 

9,358,471

その他の資本の構成要素

6,669,736

 

4,794,050

親会社の所有者に帰属する持分合計

36,446,115

 

34,097,208

非支配持分

3,267,785

 

2,561,844

資本合計

39,713,900

 

36,659,053

資本及び負債の合計

71,942,909

 

68,001,354

 

E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2025-01-012025-03-31Q12025-12-312024-01-012024-03-312024-12-311falsefalsefalse216002023-12-31216002024-12-31216002024-01-012024-03-31216002024-03-31216002025-01-012025-03-31216002025-03-31216002025-05-15216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-12-31jpigp_cor:ShareCapitalIFRSMember216002024-12-31jpigp_cor:CapitalSurplusIFRSMember216002024-12-31jpigp_cor:TreasurySharesIFRSMember216002024-12-31jpigp_cor:RetainedEarningsIFRSMember216002024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-03-31jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-03-31jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-03-31jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-03-31jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-03-31jpigp_cor:NonControllingInterestsIFRSMember216002024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-03-31jpigp_cor:ShareCapitalIFRSMember216002024-03-31jpigp_cor:CapitalSurplusIFRSMember216002024-03-31jpigp_cor:TreasurySharesIFRSMember216002024-03-31jpigp_cor:RetainedEarningsIFRSMember216002024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-03-31jpigp_cor:NonControllingInterestsIFRSMember216002025-01-012025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-01-012025-03-31jpigp_cor:ShareCapitalIFRSMember216002025-01-012025-03-31jpigp_cor:CapitalSurplusIFRSMember216002025-01-012025-03-31jpigp_cor:TreasurySharesIFRSMember216002025-01-012025-03-31jpigp_cor:RetainedEarningsIFRSMember216002025-01-012025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-01-012025-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-01-012025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-01-012025-03-31jpigp_cor:NonControllingInterestsIFRSMember216002025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-03-31jpigp_cor:ShareCapitalIFRSMember216002025-03-31jpigp_cor:CapitalSurplusIFRSMember216002025-03-31jpigp_cor:TreasurySharesIFRSMember216002025-03-31jpigp_cor:RetainedEarningsIFRSMember216002025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-03-31jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-03-31jpcrp_cor:ReportableSegmentsMember216002024-01-012024-03-31tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-03-31tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002025-01-012025-03-31jpcrp_cor:ReportableSegmentsMember216002025-01-012025-03-31tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002025-01-012025-03-31tse-qcediffr-21600:MedicalDeviceReportableSegmentMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure